Question 1 of 5
Scenario B. Using the resistance-fraction table under a chemotherapy drug pressure, describe the trend and explain it as continuing evolution.
| Month | Resistant fraction |
|---|---|
| 0 | 0.01 |
| 3 | 0.33 |
| 6 | 0.74 |
Responses receive AI feedback against a rubric after submission. Scores are practice estimates.
Scenario B. Using the resistance-fraction table under a chemotherapy drug pressure, describe the trend and explain it as continuing evolution.
| Month | Resistant fraction |
|---|---|
| 0 | 0.01 |
| 3 | 0.33 |
| 6 | 0.74 |
Scenario B. Propose a new investigation to test whether a weed population is evolving glyphosate resistance, including a comparison that strengthens causal inference.
Scenario B. Explain how continuous fossil morphological change and modern genomic surveillance are complementary evidence that evolution is ongoing.
Scenario B. Evaluate an experimental design that samples bacteria only after antibiotic failure with no baseline sample. Propose an improvement.
Scenario B. Connect pesticide resistance, antibiotic resistance, and chemotherapy resistance as parallel cases of continuing evolution.